GLP-1 drugs have transformed lives, for good and bad. Here's what happens to your heart, liver, skin, and more ...

Eamon Quinn: 'Prosperity across the island is tied to tech titans such as Apple, Intel and Microsoft, but is also linked to ...

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic ...

Novo Nordisk A/S remains a Buy despite CagriSema setback; Eli Lilly and Company remains a Hold on valuation. Click for this ...

Novo Nordisk (NVO) stock is in focus as a study estimates generic semaglutide (Ozempic/Wegovy) could cost under $3/month as its patents expire this year. Read more here.

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

New research has found that people taking medications such as Mounjaro or Wegovy for weight loss purposes may regain the majority of the weight they lost when they stop taking it. The jabs, also known ...

A new study has looked into what happens when people stop taking weight-loss jabs ...

Aspen Pharmacare aims to secure sub‑Saharan African approval for Eli Lilly's blockbuster weight‑loss drug Mounjaro as early ...